Radioactive Isotopes in Clinical Medicine and Research

1. Front Matter

   Pages I-XVIII

   PDF

2. The Badgastein Lecture

   1. Front Matter

      Pages 1-1

      PDF

   2. Nuclear Medicine — Tool or Specialty?

      • R. Höfer

      Pages 3-7

3. Lung; Therapy

   1. Front Matter

      Pages 9-9

      PDF

   2. Ventilation Scintigraphy of the Tympanic Cavity by Xenon-133

      • B. Kroker, W. Brenner, K. H. Bohuslavizki, J.-U. Eberhardt, M. Schramm, H. Wolf et al.

      Pages 11-16

   3. Assessment of Lung Injury with 67Gallium in Patients with Pulmonary Edema. A Preliminary Analysis

      • P. G. H. M. Raijmakers, A. B. J. Groeneveld, G. J. J. Teule, L. G. Thijs

      Pages 17-22

   4. A Model for Administered 81Krm Activity and a Method for Measurement: Some Recommendations for Patient and Staff Dose Reduction

      • W H Thomson, P Childs, N R Williams, L K Harding

      Pages 23-28

   5. Dosimetry of Intralesional 131I-Monoclonal Antibody (MAb) Therapy in Patients with Recurrent High Grade Gliomas

      • S. Chittenden, R. Thomas, A. Hall, T. Smith, G. Flux, M. Brada et al.

      Pages 29-34

   6. Improved Control of Malignant Gliomas by Means of Intralesional Radioimmunotherapy

      • P. Riva, A. Arista, C. Sturiale, G. Franceschi, A. Spinelli, F. Campori et al.

      Pages 35-41

4. Oncology

   1. Front Matter

      Pages 43-43

      PDF

   2. Thrombocytopenia in HIV, Idiopathic Thrombocytopenic Purpura (ITP), Vasculitis and Toxic Bone Marrow Injury: An Etiologic Entity ? Results of a Comparative Study

      • Th. Behr, W. Becker, H.-J. Bair, J. Schwab, F. Wolf

      Pages 45-50

   3. 67Ga Scintigraphy, MRI and CT in the Follow-Up of Malignant Lymphoma Patients with Residual Mediastinal Mass

      • M. Aas, H. H. Lien, O. Nome, M. Winderen, B. Hager, S. Kvaløy et al.

      Pages 51-56

   4. Tumor Imaging Using a Tc-99m Labelled Immunomodulatorresults of Clinical Studies in Various Kinds of Malignant Tumors

      • W.-G. Franke, R. Koch, U. Ehrenfeld, R. Haas, H.-M. Penzler

      Pages 57-63

   5. Investigation of Breast Cancer with 18Fluordeoxyglucose Using Conventional Gamma Camera System and Spect-Technique

      • L.-H. Holle, S. Lung-Kurt, M. Fuchs, C. Alexander, C. E. Villena-Heinsen, W. Schmidt et al.

      Pages 65-70

   6. Comparison of 123I-α-Methyltyrosine SPECT and 11C-L-Methionine PET in Patients with Brain Tumors

      • M. Weckesser, K. J. Langen, B. Hamacher, K. Ziemons, H. Herzog, T. Kuwert et al.

      Pages 71-75

5. Instrumentation; Image Processing

   1. Front Matter

      Pages 77-77

      PDF

   2. PET Image Reconstruction for Pharmacokinetic Modeling of 5-[18F]Fluorouracil in Liver Tumors

      • Matthias E. Bellemann, Josef Doll, Gunnar Brix, Uwe Haberkorn, Hermann J. Ostertag, Ludwig G. Strauss et al.

      Pages 79-84

   3. Effects of Distorted PET Projection Data on the Reconstructed Image Using Different Reconstruction Algorithms

      • Josef Doll, Hermann J. Ostertag, Matthias E. Bellemann, Peter Schmidlin, Wolfgang K. Kübler, Ludwig G. Strauss et al.

      Pages 85-90

   4. Noninvasive Determination of the Arterial Input Function: General Description for an Artery Surrounded by Homogeneous Tissue

      • G. Glatting, F. Kocher, E. Mate, R. Weller, E. Miller-Schneider, M. M. Henrich et al.

      Pages 91-96

   5. Multimodal Image Registration for Radioimmunotherapy. Surface Landmark and Frame Based Correlation in Patients Undergoing Intralesional 131I-MAb Therapy for Recurrent High Grade Glioma

      • R. Thomas, G. Flux, S. Chittenden, B. Cronin, M. Brada, D. G. T. Thomas et al.

      Pages 97-104

With the present Badgastein Symposium "Radioactive Isotopes in Clinical Medicine and Research" we have now had 40 years of an uninterrupted series of Badgastein meetings on nuclear medicine, since the first one took place in January 1954. We believe that this anni­ versary is worth mentioning. The 21 st symposium proved again to offer a representative cross­ section through the current topics of scientific interest of nuclear medicine. The general theme of research in nuclear medicine has shifted from the spectacular new developments which were so often reported in the first symposia to a less spectacular, albeit equally important period, which may best be characterized by validation and standardization. While this may not be as exciting as we would like it to be, it is nevertheless vital for nuclear medicine to maintain and improve its standing amongst the other specialties of medicine which draw upon the services that nuclear medicine offers.

• Nuklearmedizin
• Pharmakologie
• nuclear medicine
• pharmacology
• research

• Department of Biomedical Engineering and Physics, University of Vienna, Vienna, Austria

  Helmar Bergmann

• Department of Nuclear Medicine, University of Vienna, Vienna, Austria

  Helmut Sinzinger

Policies and ethics